Interacting symbionts and immunity in the amphibian skin mucosome predict disease risk and probiotic effectiveness

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Woodhams, Douglas C ^a,b,f   Brandt, Hannelore ^a   Baumgartner, Simone ^a,g,h   Kielgast, Jos ^c,i   Küpfer, Eliane ^a,d   Tobler, Ursina ^a,e   Davis, Leyla R ^a   Schmidt, Benedikt R ^a,e   Bel, Christian ^a   Hodel, Sandro ^a   Knight, Rob ^b   McKenzie, Valerie ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^e KARCH Switzerland   (Switzerland)

^f UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^g SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^h ETH ZURICH   (Switzerland)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALYTES OBSTETRICANS; AMPHIBIA; ANTIFUNGAL ACTIVITY; ANURA; ARTICLE; BATRACHOCHYTRIUM DENDROBATIDIS; CHYTRIDIOMYCOSIS; CLINICAL EFFECTIVENESS; COCULTURE; COMPETITION; CONTROLLED STUDY; CORRELATION ANALYSIS; EUROPE; FUNGAL VIRULENCE; IN VITRO STUDY; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; METABOLITE; MICROBIAL COMMUNITY; MUCUS; NONHUMAN; PREVALENCE; SKIN; SURVIVAL; SWITZERLAND; SYMBIONT; TEMPERATURE; ERRATUM; ERROR;

AMPHIBIANS; ANIMALS; CHYTRIDIOMYCOTA; HOST-PATHOGEN INTERACTIONS; MUCOUS MEMBRANE; PROBIOTICS; SKIN; SYMBIOSIS;

EID: 84904977891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096375     Document Type: Article

References (71)

1. Bletz MC, Loudon AH, Becker MH, Bell SC, Woodhams DC, et al. (2013) Mitigating amphibian chytridiomycosis with bioaugmentation: characteristics of effective probiotics and strategies for their selection and use. Ecol Lett 16: 807-820.
2. Hoffmann DE, Fraser CM, Palumbo FB, Ravel J, Rothenberg K, et al. (2013) Probiotics: Finding the right regulatory balance. Science 342: 314-315.
3. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. (2009) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547.
4. Britton RA, Young VB (2012) Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20: 313-319.
5. Belden LK, Harris RN (2007) Infectious diseases in wildlife: the community ecology context. Front Ecol Environ 5: 533-539. (Pubitemid 350224438)
6. Lafferty KD (2010) Interacting parasites. Science 330: 187-188.
7. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: An integrative view. Cell 148: 1258-1270.
8. Daskin JH, Alford RA (2012) Context-dependent symbioses and their potential roles in wildlife diseases. Proc Roy Soc B 279: 1457-1465.
9. Burgman MA, Ferson S, Akçakaya HR (1993) Risk assessment in conservation biology. London: Chapman & Hall.
10. Murray KA, Skerratt LF (2012) Predicting wild hosts for amphibian chytridiomycosis: integrating host life-history traits with pathogen environmental requirements. Human and Ecological Risk Assessment 18: 200-224.
11. Woodhams DC, Voyles J, Lips KR, Carey C, Rollins-Smith LA (2006) Predicted disease susceptibility in a Panamanian amphibian assemblage based on skin peptide defenses. J Wildl Dis 42: 207-218. (Pubitemid 44317377)
12. Gascon C, Collins JP, Moore RD, Church DR, McKay JE, et al, editors. (2007) Amphibian Conservation Action Plan. Gland: IUCN/SSC Amphibian Specialist Group.
13. Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9: 244-253.
14. Rosenthal M, Goldberg D, Aiello A, Larson E, Foxman B (2011) Skin microbiota: Microbial community structure and its potential association with health and disease. Infect Gen Evol 11: 839-848.
15. Stecher B, Chaffron S, Käppeli R, Hapfelmeier S, Freedrich S, et al. (2010) Like will to like: Abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Patho. 6: e1000711.
16. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, et al. (2012) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103.
17. Ross EM, Moate PJ, Marett LC, Cocks BG, Hayes BJ (2013) Metagenomic predictions: From microbiome to complex health and environmental phenotypes in humans and cattle. PLoS ONE 8: e73056.
18. Skerratt LF, Berger L, Speare R, Cashins S, McDonald KR, et al. (2007) Spread of chytridiomycosis has caused the rapid global decline and extinction of frogs. Ecohealth 4: 125-134. (Pubitemid 47038075)
19. Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, et al. (2012) Emerging fungal threats to animal, plant and ecosystem health. Nature 484: 186-194.
20. Murray KA, Skerratt LF, Garland S, Kriticos D, McCallum H (2013) Whether the weather drives patterns of endemic amphibian chytridiomycosis: A pathogen proliferation approach. PLoS ONE 8: e61061.
21. Vredenburg VT, Briggs CJ, Harris RN (2011) Host-pathogen dynamics of amphibian chytridiomycosis: the role of the skin microbiome in health and disease. In: Olsen L, Choffnes E, Relman DA, Pray L, editors.Fungal diseases: an emerging challenge to human, animal, and plant health. Washington, DC: The National Academies Press. pp. 342-355.
22. Harris RN, Brucker RM, Walke JB, Becker MH, Schwantes CR, et al. (2009) Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. ISME J 3: 818-824.
23. Becker MH, Harris RN, Minbiole KP, Schwantes CR, Rollins-Smith LA, et al. (2011) Towards a better understanding of the use of probiotics for preventing chytridiomycosis in Panamanian golden frogs. Ecohealth 8: 501-506.
24. Woodhams DC, Geiger CC, Reinert LK, Rollins-Smith LA, Lam B, et al. (2012) Treatment of amphibians infected with chytrid fungus: learning from failed trials with itraconazole, antimicrobial peptides, bacteria, and heat therapy. Dis Aquat Org 98: 11-25.
25. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, et al. (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73: 386S-392S. (Pubitemid 32113260)
26. Kesarcodi-Watson A, Kaspar H, Lategan MJ, Gibson L (2008) Probiotics in aquaculture: The need, principles and mechanisms of action and screening processes. Aquaculture 274: 1-14.
27. Searle CL, Gervasi SS, Hua J, Hammond JI, Relyea RA, et al. (2011) Differential host susceptibility to Batrachochytrium dendrobatidis, an emerging amphibian pathogen. Cons Bio 25: 965-974.
28. Balaz V, Vörös J, Civiš P, Vojar J, Hettyey A, et al. (2014) Assessing risk and guidance on monitoring of Batrachochytrium dendrobatidis in Europe through identification of taxonomic selectivity of infection. Cons Bio 28: 213-223.
29. Rödder D, Kielgast J, Bielby J, Schmidtlein S, Bosch J, et al. (2009) Global amphibian extinction risk assessment for the panzootic chytrid fungus. Diversity 1: 52-66.
30. Johnson PTJ, Preston DL, Hoverman JT, Richgels KLD (2013). Biodiversity reduces disease through predictable changes in host community competence. Nature 494: 230-234.
31. Loudon AH, Woodhams DC, Parfrey LW, Archer H, Knight R (2013) Microbial community dynamics and the effect of environmental reservoirs on red-backed salamanders (Plethodon cinereus). ISME J doi: 10.1038/ismej.2013.200.
32. Woodhams DC, Vredenburg VT, Simon MA, Billheimerd D, Shakhtourd B, et al. (2007) Symbiotic bacteria contribute to innate immune defenses of the threatened mountain yellow-legged frog, Rana muscosa. Biol Cons 138: 390-398. (Pubitemid 47187300)
33. Walke JB, Harris RN, Reinert LK, Rollins-Smith LA, Woodhams DC (2011) Social immunity in amphibians: Evidence for vertical transmission of innate defenses. Biotropica 43: 396-400.
34. Boyle DG, Boyle DB, Olsen V, Morgan JAT, Hyatt AD (2004) Rapid quantitative detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples using real-time Taqman PCR assay. Dis Aquat Org 60: 141-148. (Pubitemid 39588268)
35. Rollins-Smith LA, Doersam JK, Longcore JE, Taylor SK, Shamblin JC, et al. (2002) Antimicrobial peptide defenses against pathogens associated with global amphibian declines. Dev Comp Immunol 26: 63-72. (Pubitemid 33010815)
36. Daum JM, Davis LR, Bigler L, Woodhams DC (2012) Hybrid advantage in skin peptide immune defenses of water frogs (Pelophylax esculentus) at risk from emerging pathogens. Infect Genet Evol 12: 1854-1864.
37. Stockwell MP, Clulow J, Mahony MJ (2010). Efficacy of SYBR 14/propidium iodide viability stain for the amphibian chytrid fungus Batrachochytrium dendrobatidis. Dis Aquat Org 88: 177-181.
38. Farrer RA, Weinert LA, Bielby J, Garner TWJ, Balloux F, et al. (2011) Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineage. Proc Natl Acad Sci USA 108: 18732-18736.
39. Barrios V, Olmeda C, Ruiz E, compilers (2012). Action plan for the conservation of the common midwife toad (Alytes obstetricans) in the European Union. Brussels: European Commission.
40. Tobler U, Schmidt BR (2010) Within- and among-population variation in chytridiomycosis-induced mortality in the toad Alytes obstetricans . PLoS ONE 5: e10927 doi:10.1371/journal.pone.0010927
41. Rollins-Smith LA, Woodhams DC (2011) Amphibian immunity: staying in tune with the environment. In: Demas GE, Nelson RJ, editors.Ecoimmunology.New York: Oxford University Press. pp. 92-143.
42. Pask J, Woodhams DC, Rollins-Smith LA (2012) The ebb and flow of antimicrobial skin peptides defends northern leopard frogs, Rana pipiens, against chytridiomycosis. Global Change Bio 18: 1231-1238.
43. Woodhams DC, Bell SC, Kenyon N, Alford RA, Rollins-Smith LA (2012) Immune evasion or avoidance: Fungal skin infection linked to reduced defence peptides in Australian green-eyed treefrogs, Litoria serrata. Fun Bio 116: 1203-1211.
44. Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, et al. (2009) The alyteserins: Two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae). Peptides 30: 1069-1073.
45. Schloss PD, Allen HK, Klimowicz AK, Mlot C, Gross JA, et al. (2010) Psychrotrophic strain of J anthinobacterium lividum from a cold Alaskan soil produces prodigiosin. DNA and Cell Biology 29: 533-541.
46. Kiesecker JM, Blaustein AR, Belden LK (2001) Complex causes of amphibian population declines. Nature 410: 681-684. (Pubitemid 32290352)
47. Pounds JA, Bustamante MR, Coloma LA, Consuegra JA, Fogden MPL, et al. (2006) Widespread amphibian extinctions from epidemic disease driven by global warming. Nature 439: 161-167. (Pubitemid 43083133)
48. Woodhams DC, Alford RA, Briggs CJ, Johnson M, Rollins-Smith LA (2008) Life-history trade-offs influence disease in changing climates: Strategies of an amphibian pathogen. Ecology 89: 1627-1639.
49. Doddington BJ, Bosch J, Oliver JA, Grassly NC, Garcia G, et al. (2013) Context-dependent amphibian host population response to an invading pathogen. Ecology 94: 1795-1804.
50. Fites JS, Ramsey JP, Holden WM, Collier SP, Sutherland DM, et al. (2013) The invasive chytrid fungus of amphibians paralyzes lymphocyte responses. Science 342: 366-369.
51. Voyles J, Rosenblum EB, Berger L (2011) Interactions between Batrachochytrium dendrobatidis and its amphibian hosts: a review of pathogenesis and immunity. Microbes & Infect 13: 25-32.
52. Conlon JM (2011) Structural diversity and species distribution of host-defense peptides in frog skin secretions. Cell Molec Life Sci 68: 2303-2315.
53. Meltser S, Bishop PJ (2009) Skin peptide defences of New Zealand frogs against chytridiomycosis. Anim Cons 13: 44-52.
54. Crawford AJ, Lips KR, Bermingham E (2010) Epidemic disease decimates amphibian abundance, species diversity, and evolutionary history in the highlands of central Panama. Proc Natl Acad Sci USA 107: 13777-13782.
55. Newman DG, Bell BD, Bishop PJ, Burns R, Haigh A, et al. (2010) Conservation status of New Zealand frogs, 2009. N Zeal J Zool 37: 121-130.
56. Brucker RM, Harris RN, Schwantes CR, Gallaher TN, Flaherty DC, et al. (2008) Amphibian chemical defense: Antifungal metabolites of the microsymbiont Janthinobacterium lividum on the salamander Plethodon cinereus. J Chem Ecol 34: 1422-1429.
57. Salinas I, Abelli L, Bertoni F, Picchietti S, Roque A, et al. (2008) Monospecies and multispecies probiotic formulations produce different systemic and local immunostimulatory effects in the gilthead seabream (Sparus aurato L.). Fish & Shellfish Immunol 25: 114-123.
58. Küng D, Bigler L, Davis LR, Gratwicke B, Griffith E, et al. (2013) Stability of microbiota on a Panamanian frog: insights for probiotic therapy against disease. PLoS ONE 9(1): e87101. doi:10.1371/journal.pone.0087101.
59. Schadich E, Cole ALJ (2009) Inhibition of frog antimicrobial peptides by extracellular products of the bacterial pathogen Aeromonas hydrophila. Lett Appl Microbiol 49: 384-387.
60. Schadich E (2009) Skin peptide activities against opportunistic bacterial pathogens of the African clawed frog (Xenopus laevis) and three Litoria frogs. J Herpetol 43: 173-183.
61. McKenzie VJ, Bowers RM, Fierer N, Knight R, Lauber CL (2012) Co-habiting amphibian species harbor unique skin bacterial communities in wild populations. ISME J 6: 588-596.
62. Kueneman JG, Parfrey LW, Woodhams DC, Archer HM, Knight R, McKenzie VJ (2013) The amphibian skin microbiome across species, space and life history stages. Mol Ecol doi: 10.1111/mec.12510.
63. Delplace F, Maes E, Lemoine J, Strecker G (2002) Species specificity of O-linked carbohydrate chains of the oviducal mucins in amphibians: structural analysis of neutral oligosaccharide alditols released by reductive beta-elimination from the egg-jelly coats of Rana clamitans. Biochem J 363: 457-471. (Pubitemid 34526366)
64. Varki A (1993) Biological roles of oligosaccharides - all of the theories are correct. Glycobiol 3: 97-130.
65. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, et al(2009) The NIH Human Microbiome Project. Genome Res 19: 2317-2323.
66. Cotter PD, Ross RP, Hill C (2013) Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11: 95-105.
67. Williamson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper FJ, et al. (2007) Anticancer and immunosuppressive properties of bacterial prodiginines. Future Microbiol 2: 605-618.
68. Wilson M (2005) Microbial inhabitants of humans: their ecology and role in health and disease. Cambridge: Cambridge University Press.
69. Hancock REW, Nijnik A, Philpott DJ (2012) Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 10: 243-254.
70. Myers JM, Ramsey JP, Blackman AL, Nichols AE, Minbiole KPC, et al. (2012) Synergistic inhibition of the lethal fungal pathogen Batrachochytrium dendrobatidis: The combined effect of symbiotic bacterial metabolites and antimicrobial peptides of the frog Rana muscosa. J Chem Ecol 38: 958-965.
71. Becker J, Eisenhauer N, Scheu S, Jousset A (2012) Increasing antagonistic interactions cause bacterial communities to collapse at high diversity. Ecol Lett 15: 468-474.